Question 1

Why This Test is Important

Accepted Answer

Determines patient eligibility for targeted therapies like crizotinib. Enhances treatment success rates compared to traditional chemotherapy. Provides precise insights into the tumor's genetic profile.

Question 2

Target Groups

Accepted Answer

Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC). Individuals seeking personalized oncology treatment plans. Patients requiring molecular subtyping of lung tumors.

Question 3

Procedure and Methodology

Accepted Answer

Performed on tumor tissue biopsy or through liquid biopsy (blood). Utilizes advanced methods like FISH or Next-Generation Sequencing (NGS). Results guide the oncologist in selecting the most effective medication.

Targeted Lung Cancer Therapy Guide - ROS1 Gene Rearrangement Testing for Lung Cancer